Pasithea Therapeutics Corp.

KTTA | NASDAQ | 1 Followers
$0.84 -0.62% $0.0053
Follow
Loading...

Profile

Pasithea Therapeutics Corp. (KTTA) is an American biotechnology company focused on the development and commercialization of new treatments for neurological and psychiatric disorders. With an emphasis on innovative approaches to treating depression, anxiety, and other mental health conditions, Pasithea is a leading player in the field of neuroscience research. The company is known for its strong focus on the research and development of new therapeutic solutions that can improve patients' quality of life. Pasithea Therapeutics also collaborates with academic and scientific institutions to accelerate innovation in its field. Pasithea Therapeutics Corp. (KTTA) shares could be suitable for investors looking to invest in biotechnology and healthcare with the potential for breakthrough discoveries in mental health treatment.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade